Endpoints for randomized controlled clinical trials for COVID-19 treatments

Lori E. Dodd, Dean Follmann, Jing Wang, Franz Koenig, Lisa L. Korn, Christian Schoergenhofer, Michael A. Proschan, S. Hunsberger, Tyler Bonnett, Mat Makowski

Type: Preprint

Publication Date: 2020-01-01

Citations: 0

DOI: https://doi.org/10.48550/arxiv.2006.10533

View Publication

Locations

arXiv (Cornell University) - View
Europe PMC (PubMed Central) - View - PDF
Lancaster EPrints (Lancaster University) - View - PDF
DataCite API - View

Similar Works

Action	Title	Year	Authors
+	Endpoints for randomized controlled clinical trials for COVID-19 treatments	2020	Lori E. Dodd Dean Follmann Jing Wang Franz Koenig Lisa L. Korn Christian Schoergenhofer Michael A. Proschan S. Hunsberger Tyler Bonnett Mat Makowski
+ PDF Chat	Endpoints for randomized controlled clinical trials for COVID-19 treatments	2020	Lori E. Dodd Dean Follmann Jing Wang Franz Koenig Lisa L. Korn Christian Schoergenhofer Michael A. Proschan Sally Hunsberger Tyler Bonnett Mat Makowski
+	Definitions and elements of endpoints in phase III randomized trials for the treatment of COVID-19: a cross-sectional analysis of trials registered in ClinicalTrials.gov	2021	Kentaro Sakamaki Yukari Uemura Yosuke Shimizu
+	Clinical Design for Phase II/III Clinical Trials for Testing Therapeutic Interventions in COVID-19 Patients	2020	N. Shesh Qian Chen Jianmin Pan Anand Seth Deo Kumar Srivast Aruni Bhatnagar
+ PDF Chat	Endpoints used in phase III randomized controlled trials of treatment options for COVID-19	2020	Aakash Desai Bishal Gyawali
+	Statistical Design of Phase II/III Clinical Trials for Testing Therapeutic Interventions in COVID-19 Patients	2020	N. Shesh Qian Chen Jianmin Pan Anand Seth Deo Kumar Srivast Aruni Bhatnagar
+	Statistical Design of Phase II/III Clinical Trials for Testing Therapeutic Interventions in COVID-19 Patients	2020	N. Shesh Qian Chen Jianmin Pan Anand Seth Deo Kumar Srivast Aruni Bhatnagar
+ PDF Chat	Statistical design of Phase II/III clinical trials for testing therapeutic interventions in COVID-19 patients	2020	N. Shesh Chen Qian Jianmin Pan Anand K. Seth Deo Kumar Srivastava Aruni Bhatnagar
+ PDF Chat	Statistical Opportunities to Accelerate Development for COVID-19 Therapeutics	2020	Fanni Natanegara Névine Zariffa Joan Buenconsejo Ran Liao Freda Cooner Divya Lakshminarayanan Samiran Ghosh Jerald Schindler Margaret Gamalo
+ PDF Chat	Design aspects of COVID‐19 treatment trials: Improving probability and time of favorable events	2021	Jan Beyersmann Tim Friede Claudia Schmoor
+ PDF Chat	Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment, for binary, ordinal, and time‐to‐event outcomes	2020	David Benkeser Iván Díaz Alex Luedtke Jodi B Segal Daniel O. Scharfstein Michael Rosenblum
+ PDF Chat	Evaluating treatment efficacy in hospitalized COVID-19 patients, with applications to Adaptive COVID-19 Treatment Trials	2024	D. Y. Lin J. Wang Yu Gu Donglin Zeng
+	Highly efficient clinical trial designs for reliable screening of under-performing treatments: Application to the COVID-19 Pandemic	2020	Steven Piantadosi
+ PDF Chat	A seamless Phase I/II platform design with a time-to-event efficacy endpoint for potential COVID-19 therapies	2024	Thomas Jaki Helen Barnett Andrew Titman Pavel Mozgunov
+	Improving Precision and Power in Randomized Trials for COVID-19 Treatments Using Covariate Adjustment, for Binary, Ordinal, and Time-to-Event Outcomes	2020	David Benkeser Iván Díaz Alex Luedtke Jodi B Segal Daniel O. Scharfstein Michael Rosenblum
+	A Seamless Phase I/II Platform Design with a Time-To-Event Efficacy Endpoint for Potential COVID-19 Therapies	2020	Thomas Jaki Helen Barnett Andrew Titman Pavel Mozgunov
+	Randomized controlled trials in patients with COVID-19: a systematic review and critical appraisal	2022	Kavina Kudhail Jacqueline Thompson Vivek Mathews Breanna Morrison Karla Hemming
+	Design aspects of COVID-19 treatment trials: Improving probability and time of favourable events	2020	Jan Beyersmann Tim Friede Claudia Schmoor
+	Efficient adaptive designs for clinical trials of interventions for COVID-19	2020	Nigel Stallard Lisa V. Hampson Norbert Benda Werner Brannath Thomas Burnett Tim Friede Peter Kimani Franz Koenig Johannes Krisam Pavel Mozgunov
+ PDF Chat	How to Quantify and Interpret Treatment Effects in Comparative Clinical Studies of COVID-19	2021	Lü Tian Jason L. Vassy Christine S. Ritchie Chien‐Chang Lee Dae Hyun Kim

Works That Cite This (0)

Action	Title	Year	Authors

Works Cited by This (0)

Action	Title	Year	Authors